Organogenesis Ownership | Who Owns Organogenesis?


OverviewForecastRevenueFinancialsChartTranscripts

Organogenesis Ownership Summary


Organogenesis is owned by 14.49% institutional investors, 45.96% insiders, and 39.56% retail investors. Soleus capital management is the largest institutional shareholder, holding 9.42% of ORGO shares. Xtrackers S&P 500 2xLev Dly Swap ETF 1C is the top mutual fund, with 1.82% of its assets in Organogenesis shares.

ORGO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrganogenesis14.49%45.96%39.56%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Soleus capital management12.48M9.42%$39.95M
Morgan stanley11.58M8.78%$32.41M
Blackrock funding, inc. /de5.28M3.98%$16.88M
Blackrock5.09M3.86%$14.24M
Vanguard group3.59M2.71%$11.49M
Acadian asset management3.08M2.33%$9.87M
Assenagon asset management2.95M2.23%$9.44M
Dimensional fund advisors lp2.79M2.10%$8.93M
Deutsche bank ag\2.45M1.85%$7.84M
Geode capital management1.74M1.31%$5.56M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Soleus capital management12.48M2.51%$39.95M
Intrepid family office105.00K0.35%$336.00K
Wealth dimensions group407.96K0.32%$1.31M
Kent lake capital151.91K0.19%$425.33K
Ajovista15.51K0.13%$43.44K
Virtus investment advisers49.00K0.12%$156.80K
Gsa capital partners llp354.15K0.08%$1.13M
Omnistar financial group31.00K0.08%$99.20K
Capital square22.60K0.05%$80.46K
Acadian asset management3.08M0.03%$9.87M

Top Buyers

HolderShares% AssetsChange
Assenagon asset management2.95M0.02%1.04M
Soleus capital management12.48M2.51%645.00K
Norges bank482.20K0.00%482.20K
Dimensional fund advisors lp2.79M0.00%442.77K
Goldman sachs group656.16K0.00%383.52K

Top Sellers

HolderShares% AssetsChange
Deutsche bank ag\2.45M0.00%-2.39M
Aqr capital management1.52M0.01%-1.19M
Healthcare of ontario pension plan trust fund---649.90K
Nuveen asset management338.06K0.00%-436.31K
Thompson siegel & walmsley---429.18K

New Positions

HolderShares% AssetsChangeValue
Norges bank482.20K0.00%482.20K$1.54M
State of wisconsin investment board182.67K0.00%182.67K$584.53K
Kent lake capital151.91K0.19%151.91K$425.33K
Intrepid family office105.00K0.35%105.00K$336.00K
Jump financial97.95K0.01%97.95K$313.44K

Sold Out

HolderChange
Assetmark-4.00
Northwestern mutual wealth management-10.00
Nelson, van denburg & campbell wealth management group-13.00
Old point trust & financial services n a-250.00
Allspring global investments-570.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202443-61.61%19,203,473-69.76%140.63%19-64.15%11-71.79%
Sep 30, 2024112-4.27%63,509,8320.99%472.11%53-26.39%3930.00%
Jun 30, 2024117-6.40%62,887,60411.28%472.56%7212.50%30-31.82%
Mar 31, 202412513.64%56,511,096-2.87%432.20%6418.52%4422.22%
Dec 31, 20231101.85%58,178,34411.66%442.81%5412.50%36-2.70%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Xtrackers S&P 500 2xLev Dly Swap ETF 1C2.41M1.82%-
Xtrackers S&P Global Infra Swap ETF 1C2.08M1.64%-
iShares Russell 2000 ETF1.85M1.46%-16.00K
Vanguard Total Stock Mkt Idx Inv1.66M1.31%-
Vanguard US Total Market Shares ETF1.59M1.25%-
Vanguard Institutional Extnd Mkt Idx Tr1.10M0.87%-
Fidelity Small Cap Index720.99K0.57%-13.50K
iShares Russell 2000 Value ETF561.91K0.44%-
DFA US Small Cap Value I501.60K0.40%20.15K
Dimensional US Targeted Value ETF493.33K0.39%4.79K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 04, 2025Driscoll Michael Joseph-Sell$127.53K
Dec 16, 2024Gillheeney Gary S. President and CEOSell$19.49K
Dec 13, 2024Gillheeney Gary S. President and CEOSell$186.87K
Dec 11, 2024Gillheeney Gary S. President and CEOSell$573.11K
Dec 12, 2024Gillheeney Gary S. President and CEOSell$153.92K

Insider Transactions Trends


DateBuySell
2025 Q1-1
2024 Q4-7
2024 Q3--
2024 Q2--
2024 Q1-4

ORGO Ownership FAQ


Who Owns Organogenesis?

Organogenesis shareholders are primarily institutional investors at 14.48%, followed by 45.96% insiders and 39.55% retail investors. The average institutional ownership in Organogenesis's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Organogenesis falls below.

Who owns the most shares of Organogenesis?

Organogenesis’s largest shareholders are Soleus capital management (12.48M shares, 9.42%), Morgan stanley (11.58M shares, 8.78%), and Blackrock funding, inc. /de (5.28M shares, 3.98%). Together, they hold 22.18% of Organogenesis’s total shares outstanding.

Does Blackrock own Organogenesis?

Yes, BlackRock owns 3.86% of Organogenesis, totaling 5.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.24M$. In the last quarter, BlackRock increased its holdings by 112.84K shares, a 2.27% change.

Who is Organogenesis’s biggest shareholder by percentage of total assets invested?

Soleus capital management is Organogenesis’s biggest shareholder by percentage of total assets invested, with 2.51% of its assets in 12.48M Organogenesis shares, valued at 39.95M$.

Who is the top mutual fund holder of Organogenesis shares?

Xtrackers S&P 500 2xLev Dly Swap ETF 1C is the top mutual fund holder of Organogenesis shares, with 1.82% of its total shares outstanding invested in 2.41M Organogenesis shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools